Estimates of the eligible population for Australia’s targeted National Lung Cancer Screening Program, 2025-2030

Competing Interest Statement

Karen Canfell is co-primary investigator in an investigator-initiated trial of cervical screening, 'Compass', run by the Australian Centre for Prevention of Cervical Cancer (ACPCC), a government-funded not-for-profit charity. Compass receives infrastructure support from the Australian government; the ACPCC has received equipment and a funding contribution from Roche Molecular Diagnostics, and operational support from the Australian government. Karen Canfell is also co-primary investigator in an investigator-initiated implementation program, Elimination of Cervical Cancer in the Western Pacific (ECCWP), which receives support from the Minderoo Foundation and equipment donations from Cepheid Inc. Karen Canfell also receives support for a range of other Australian and international projects related to cervical cancer control, including support from philanthropic organisations, the World Health Organization, and government agencies, together with contract funding for monitoring the safety of the National Cervical Screening Program. None of these are directly related to the study reported in this article. All other authors have no competing interest.

Funding Statement

This work was funded by a Medical Research Future Fund (MRFF) Preventive and Public Health Research Initiative: 2019 Target Health System and Community Organisation Research Grant Opportunity, No. MRF1200535.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This report uses de-identified data from the National Drug Strategy Household Survey, supplied by the Australian Institute of Health and Welfare: https://www.aihw.gov.au/about-our-data/our-data-collections/national-drug-strategy-household-survey/2022-ndshs The Australian Institute of Health and Welfare ethics committee of the Australian Institute of Health and Welfare waived ethical approval for this work. Use of the data were supplied under a Confidentiality Undertaking made in pursuance of section 29 of the Australian Institute of Health and Welfare Act 1987 (AIHW Act) to Dr Stephen Wade at Cancer Council NSW.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes